Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance

Han-Ying Cheng; Chia-Hsin Hsieh; Po-Han Lin; Yu-Tung Chen; Dennis Shin-Shian Hsu; Shyh-Kuan Tai; Pen-Yuan Chu; Muh-Hwa Yang

doi:10.1136/jitc-2022-004832

Article info

PDF

PDF +
Supplementary
Material

Basic tumor immunology

Original research

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance

Authors

Han-Ying Cheng Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articles Google scholar articles
Chia-Hsin Hsieh Institute of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articles Google scholar articles
Po-Han Lin Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articles Google scholar articles
Yu-Tung Chen Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articles Google scholar articles
Dennis Shin-Shian Hsu Asclepiumm Taiwan Co., Ltd, Taipei, Taiwan PubMed articles Google scholar articles
Shyh-Kuan Tai Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan PubMed articles Google scholar articles
Pen-Yuan Chu Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan PubMed articles Google scholar articles
Muh-Hwa Yang Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanInstitute of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, TaiwanDivsion of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan PubMed articles Google scholar articles

Citation

Cheng H, Hsieh C, Lin P, et al

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance

Journal for ImmunoTherapy of Cancer 2022;10:e004832. doi: 10.1136/jitc-2022-004832

Online issue publication

November 15, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password